Glaxo Defends Flonase From Generics With Manufacturing Spec Petition
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline is attempting to impede generic competition for itsFlonase nasal steroid with the filing of the second citizen petition this year related to the product